# FDA 483 - Eric T. Rush M.D - October 24, 2025

Source: https://www.globalkeysolutions.net/records/483/eric-t-rush-md/a727092f-e804-4b8e-9adf-c5a5cf2b747a

> FDA 483 for Eric T. Rush M.D on October 24, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eric T. Rush M.D
- Inspection Date: 2025-10-24
- Product Type: drugs
- Office Name: Kansas City District Office
- Summary: An FDA inspection of Eric T. Rush M.D. in Kansas City, MO, revealed significant deficiencies in the conduct of clinical trials. Observations included failure to follow investigational plans, such as missed study visits, unperformed study activities, delayed reporting of serious adverse events, and inadequate documentation of adverse events. Additionally, the firm experienced a lapse in IRB approval for a clinical study due to untimely submission of required documentation.

## Related Officers

- [Logan M. Jones](https://www.globalkeysolutions.net/people/logan-m-jones/286ab813-461a-4bfc-a732-bcd4f0d6e596)

Company: https://www.globalkeysolutions.net/companies/eric-t-rush-md/c504bc51-124f-4b4e-8448-7e274415597e

Office: https://www.globalkeysolutions.net/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79